At autopsy, ATTR-CA is present in approximately 25% of elderly people ≥ 85 years [32] and for most decedents with systemic amyloidosis, whereas through conventional bone scanning ATTR-CA was only detected in about 11% of patients ≥ 85 years [123]. This evidence concerns the gene TTR and primary systemic amyloidosis.